Radiofrequency Ablation (RFA) in Breast Tumors

Radiofrequency Ablation in Breast Tumors in Early Stages

To validate the efficacy and safety of the cool-tip ablation method for breast tumors smaller than 2 cm.

A prospective, phase II-III study, which will include a series of cases of 30 patients. The hospitals involved will be Bellvitge University Hospital and Hospital del Mar.

Efficacy was evaluated according magnetic resonance image and biopsy of the breast 1 month after the procedure.

Patients will be followed up over a 2-year period to assess cosmetic results, short and long-term complications and possible recurrences.

Inclusion Criteria:

• Infiltrating ductal carcinoma according the biopsy of the breast,
• Tumor visible by ultrasound, smaller than 2 cm,
• Located > 1 cm from the chest wall and the skin.

Exclusion Criteria:

• Personal antecedents of breast cancer
• Multifocality or intraductal carcinoma
• Lobular infiltrating carcinoma
• Neoadjuvant therapy